Bevacizumab for Retinopathy of Prematurity: 2-Year Neurodevelopmental Follow-up. Zayek M, Parker K, Rydzewska M, Rifai A, et al. Am J Perinatol 2020 May 23. doi: 10.1055/s-0040-1710556.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zayek M, Parker K, Rydzewska M, Rifai A, et al. Bevacizumab for Retinopathy of Prematurity: 2-Year Neurodevelopmental Follow-up. Am J Perinatol 2020 May 23. doi: 10.1055/s-0040-1710556.
PMID: 32446264